ALIPOGENE TIPARVOVEC
UNII 20OK4AFR4Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Alipogene Tiparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 20OK4AFR4Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 929881-05-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

20OK4AFR4Y

CAS Registry Number

929881-05-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ALIPOGENE TIPARVOVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166528

National Cancer Institute reference terminology for clinical and research data.

INN ID

8987

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Alipogene Tiparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ALIPOGENE TIPARVOVEC

Common Names & Synonyms

ALIPOGENE TIPARVOVEC [EMA EPAR]

ALIPOGENE TIPARVOVEC [INN]

ALIPOGENE TIPARVOVEC [WHO-DD]

DNA (SYNTHETIC ADENO-ASSOCIATED VIRUS 1 VECTOR AMT-011), COMPLEX WITH PROTEIN VP1 (ADENO-ASSOCIATED VIRUS 1) AND PROTEIN VP2 (ADENO-ASSOCIATED VIRUS 1) AND PROTEIN VP3 (ADENO-ASSOCIATED VIRUS 1)

RECOMBINANT ADENO-ASSOCIATED VIRUS SEROTYPE 1 (AAV1) VECTOR EXPRESSING THE S447X VARIANT OF THE HUMAN LIPOPROTEIN LIPASE (LPL) GENE

Brand / Trade Names

GLYBERA

External Clinical & Regulatory Resources

Previous UNII20OJ1J791A

Next UNII20OP60125T